Inactive Instrument

Insiders THERACLION N Euronext Paris

Equities

FR0010120402

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-

03-27	Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Theraclion Names CEO	26/05/23	MT
Theraclion Appoints Martin Deterre as CEO	25/05/23	CI
France's Theraclion Appoints New Chairman	24/01/22	MT
Yann Duchesne Appoints New Executive Chairman to Lead Major Shift in Theraclion’s Strategy	24/01/22	CI
Theraclion Appoints Mehdi El Glaoui to Its Board of Directors	22/06/21	CI
Theraclion SA Announces Executive Changes	28/04/20	CI
Theraclion : Christopher S. Bödtker appointed Chairman of Theraclion	28/04/20	BU
Theraclion announces the reinforcement of its Board of Directors with the nomination of a new Non-Executive Director: Mister Renaud Saleur	07/02/18	BU
Mister Renaud Saleur Joins Theraclion to its Board of Directors on February 1, 2018	07/02/18	CI
Theraclion Appoints Laurence Aucoin as Vice President Operations	16/06/16	CI
Theraclion, S.A.S. Announces Board Changes	18/05/16	CI
Theraclion Hires Dennis Guo as Business Development Director for Asia	15/04/15	CI
Theraclion Appoints Michael Leach as Vice-President UK & Northern Europe	15/12/14	CI
THERACLION Announces Executive Changes	24/11/14	CI
Theraclion, S.A.S. Announces Management Changes	02/09/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer